• This topic is empty.
Viewing 1 post (of 1 total)
  • Author
    Posts
  • #10679

    The agreement gives Brickell Biotech the right to develop AnGes’ vaccine in the U.S. and other emerging markets, following ongoing clinical studies in Japan.

    More Information

Viewing 1 post (of 1 total)
  • You must be logged in to reply to this topic.